Home Audentes Therapeutics Acquires Cardiac Gene Therapy Company Cardiogen Sciences
 

Keywords :   


Audentes Therapeutics Acquires Cardiac Gene Therapy Company Cardiogen Sciences

2015-09-02 07:53:29| drugdiscoveryonline News Articles

Audentes Therapeutics, Inc., a biotechnology company committed to the development and commercialization of gene therapy products for patients with serious, rare diseases, recently announced the acquisition of Cardiogen Sciences, Inc., a biotechnology company focused on the discovery and development of adeno-associated virus(AAV) gene therapy products for rare, inherited arrhythmogenic diseases

Tags: company sciences therapy gene

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Unpaid carers being forced to repay 250m to DWP
18.05Weekly Recap: Hempel, Axalta, KANSAI HELIOS Top This Weeks Stories
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
18.05Eastern North Pacific Tropical Weather Outlook
18.05Atlantic Tropical Weather Outlook
More »